The liver acts as the central organ in the synthesis of APPs. Upon receiving signals from cytokines, hepatocytes in the liver increase the production of positive APPs while decreasing the production of negative APPs. This process involves complex intracellular signaling pathways that lead to the activation of transcription factors such as STAT3 and NF-κB, which bind to the promoters of acute phase genes to modulate their expression.
